Update date
31 Mar 2023
Shareable Research Card
BNKL - Bionik Laboratories Corp. Return On Equity
This metric view shows BNKL - Bionik Laboratories Corp. return on equity history from SEC company facts.
Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.
- Context
- Latest reported period: Q1 2023
- Latest reported value
- 46191%
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.
Return Loop
Why revisit this metric view
This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.
- Latest source-backed update
- Latest period end 31 Mar 2023
- Why come back
- Return after the next filing to verify whether this metric changed and how it compares with the ranking page.
- Current latest reported period: Q1 2023.
- Latest reported value on this page: 46191%.
- Save this filer if you want to compare the next reported value with this history.
Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.
Latest update
Latest update for Return On Equity
Latest reported return on equity: 46191%. Open the source-backed page to compare this metric with the newest filing-backed context.
Page type
Metric history
Latest period
Q1 2023
SEC-backed company facts were refreshed from filings filed on 21 Jun 2023.
Benchmark Context
How Return On Equity compares with peers
Bionik Laboratories Corp. sits in the top quarter of the current return on equity sample.
Compared with
Compared with 120 companies reporting return on equity in %. This keeps the comparison on the same metric and unit family.
Why this is notable
This is about 26.2x the current sample midpoint. Return On Equity does not yet have enough prior-period data for a historical comparison on this page.
- Visible rows currently span reported period ends from 30 Jun 2015 to 28 Feb 2026.
- Nearby companies in this sample: Cardiff Lexington Corp and Savara Inc.
- Current sample position: rank #4 of 120 comparable companies.
- Peer rows use the latest valid value per company for this exact metric and compatible units.
Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.
Save this filer page
Create a free account to keep this page in your watchlists and return after a new SEC filing changes the record here.
Financial Metric Page
Bionik Laboratories Corp.: Return On Equity
Latest period: Q1 2023. Period end: 31 Mar 2023. Units: %. Frequency: quarterly and annual.
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Metric Snapshot
- Latest value
- 46191%
- Coverage range
- 31 Dec 2012 - 31 Mar 2023
- Fact rows
- 35
What This Metric Tells You
- Shows the reported level of return on equity over 31 Dec 2012 - 31 Mar 2023.
- Use consecutive periods in the table to assess trend direction when YoY change is unavailable.
- Built from 35 SEC fact rows for this metric and issuer.
How To Read This Chart
- Start with the latest point, then compare it with the prior periods to see direction.
- Use quarterly sequence to compare like-for-like periods.
- Use YoY change bars to separate growth from contraction across matching periods.
Official SEC Source
Source: SEC Company Facts
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Reporting periods may differ by company.
Compare This Metric Across Companies
Compare latest available Return On Equity levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.
Bionik Laboratories Corp. appears at rank #4 in the latest comparison sample.
| Rank | Company | Latest value | Reported period | Next step |
|---|---|---|---|---|
| 1 | Wellgistics Health, Inc. (wgrx) | 141760% | Year - 31 Dec 2025 | Open Wellgistics Health, Inc. Return On Equity |
| 2 | XCF Global, Inc. (safx) | 77635% | Quarter - 31 Dec 2025 | Open XCF Global, Inc. Return On Equity |
| 3 | Cardiff Lexington Corp (cdix) | 49573% | Year - 31 Dec 2025 | Open Cardiff Lexington Corp Return On Equity |
| 4 | Bionik Laboratories Corp. (bnkl) | 46191% | Quarter - 31 Mar 2023 | Open Bionik Laboratories Corp. Return On Equity |
| 5 | Savara Inc (svra) | 43610% | Year - 31 Dec 2025 | Open Savara Inc Return On Equity |
| 6 | Athenex, Inc. | 25553% | Quarter - 31 Dec 2022 | Open Athenex, Inc. Return On Equity |
Metric Details
- Metric
- Return On Equity (ROE)
- Taxonomy
- ratio
- Units tracked
- %
- Frequency coverage
- quarterly and annual
- History range
- 31 Dec 2012 - 31 Mar 2023
- Facts on this page
- 35
- Description
- Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
- Metric-level SEC endpoint
- Open SEC company concept
Chart Context
Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)
Bionik Laboratories Corp. Quarterly Return On Equity (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| Q1 2023 | 46191% | +47304% | 01 Jan 2023 | 31 Mar 2023 | |
| Q4 2022 | -468% | +483% | +51% | 01 Oct 2022 | 31 Dec 2022 |
| Q3 2022 | -7408% | -6939% | -1480% | 01 Jul 2022 | 30 Sep 2022 |
| Q2 2022 | -1875% | -1606% | -597% | 01 Apr 2022 | 30 Jun 2022 |
| Q1 2022 | -1113% | -910% | -447% | 01 Jan 2022 | 31 Mar 2022 |
| Q4 2021 | -952% | 01 Oct 2021 | 31 Dec 2021 | ||
| Q3 2021 | -469% | 01 Jul 2021 | 30 Sep 2021 | ||
| Q2 2021 | -269% | 01 Apr 2021 | 30 Jun 2021 | ||
| Q1 2021 | -204% | 01 Jan 2021 | 31 Mar 2021 | ||
| Q2 2016 | 2.9% | +1197% | 01 Apr 2016 | 30 Jun 2016 | |
| Q1 2016 | 126% | +625% | 01 Jan 2016 | 31 Mar 2016 | |
| Q4 2015 | -591% | +127% | +18% | 01 Oct 2015 | 31 Dec 2015 |
| Q3 2015 | -1079% | -50% | -4.9% | 01 Jul 2015 | 30 Sep 2015 |
| Q2 2015 | -1195% | +256% | +18% | 01 Apr 2015 | 30 Jun 2015 |
| Q1 2015 | -499% | -524% | -2118% | 01 Jan 2015 | 31 Mar 2015 |
| Q4 2014 | -718% | -739% | -3549% | 01 Oct 2014 | 31 Dec 2014 |
| Q3 2014 | -1029% | -915% | 01 Jul 2014 | 30 Sep 2014 | |
| Q2 2014 | -1450% | -1448% | -68738% | 01 Apr 2014 | 30 Jun 2014 |
| Q1 2014 | 25% | +26% | 01 Jan 2014 | 31 Mar 2014 | |
| Q4 2013 | 21% | +22% | 01 Oct 2013 | 31 Dec 2013 | |
| Q3 2013 | -114%* | 01 Jul 2013 | 30 Sep 2013 | ||
| Q2 2013 | -2.1% | 01 Apr 2013 | 30 Jun 2013 | ||
| Q1 2013 | -1.1% | 01 Jan 2013 | 31 Mar 2013 | ||
| Q4 2012 | -1.2% | 01 Oct 2012 | 31 Dec 2012 |
Bionik Laboratories Corp. Annual Return On Equity (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| 2022 | -529% | -373% | -240% | 01 Apr 2022 | 31 Mar 2023 |
| 2021 | -156% | -101% | -187% | 01 Apr 2021 | 31 Mar 2022 |
| 2020 | -54% | +43% | +44% | 01 Apr 2020 | 31 Mar 2021 |
| 2019 | -97% | -47% | -92% | 01 Apr 2019 | 31 Mar 2020 |
| 2018 | -51% | -111% | -184% | 01 Apr 2018 | 31 Mar 2019 |
| 2017 | 60% | +1038% | 01 Apr 2017 | 31 Mar 2018 | |
| 2016 | -978% | -387% | -65% | 01 Apr 2016 | 31 Mar 2017 |
| 2015 | -591% | -583% | -6876% | 01 Jan 2015 | 31 Dec 2015 |
| 2014 | -8.5% | -29% | -141% | 01 Jan 2014 | 31 Dec 2014 |
| 2013 | 21% | +22% | 01 Jan 2013 | 31 Dec 2013 | |
| 2012 | -1.2% | 01 Jan 2012 | 31 Dec 2012 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.